(Q63966646)
Statements
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis (English)
K M Pantalone
C Yu
S Arrigain
A Jain
A Atreja